French and Swiss health care spending
French health care spending rose 3.2% in the 12-month period May 2008 to April 2009, according to figures from the nation's health fund organization CNAM.
The CNAM says that spending for general practice health care in the first four months of 2009 went up 2.7% over the same period of 2008 compared with 2.6% in first quarter. Spending on drugs has continued to slow down, rising by only 1.5% in the four-month period this year compared with 1.6% in first quarter.
Swiss health spending is expected to rise by only 2.9% in 2010, compared with an earlier forecast of 3.8% by the KOF economics research bureau in Zurich. The reason for the revision is the weaker economy. The salary bill in the health service is expected to rise just 0.2% in 2010 against 1.4% this year. The KOF is maintaining its spending growth forecast of 4.3% for 2009.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze